SP

Shitla Prasad Upadhyay

Active Director Additional Director DIN 07844329
DIN 07844329 First appointment Oct 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Oct 2021
Shareholding value •••• Premium profile

About Shitla Prasad Upadhyay

Data last updated:

Shitla Prasad Upadhyay is an Additional Director at Sahid Khudiram Bose Hospital (since 2025) and Director at Cure And Care Polyclinic And Pathology Private Limited (since 2021). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹14.99 Cr; the largest is Sahid Khudiram Bose Hospital at ₹14.96 Cr (FY 2022).

DIN 07844329
Primary Designation Additional Director
Industry Healthcare
First Appointment 11 Oct 2021
Oldest Company Age 12 yrs
Largest company Sahid Khudiram Bose Hospital · ₹14.96 Cr (FY 2022)
Combined revenue ₹14.99 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sahid Khudiram Bose Hospital U85100WB2014NPL201355
Additional Director01 Jun 20252014₹14.96 Cr (FY 2022)Active
Director11 Oct 20212021₹2.9 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Cure And Care Polyclinic And Pathology Private Limited
Sahid Khudiram Bose Hospital
Premium access

Shareholding and investment profile for Shitla Prasad Upadhyay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shitla Prasad Upadhyay

Shitla Prasad Upadhyay currently holds 2 directorships: Sahid Khudiram Bose Hospital (Additional Director, since 01 Jun 2025, revenue ₹14.96 Cr (FY 2022)); Cure And Care Polyclinic And Pathology Private Limited (Director, since 11 Oct 2021, revenue ₹2.9 Lakh (FY 2024)).

Shitla Prasad Upadhyay was first appointed on 11 Oct 2021 as Director at Cure And Care Polyclinic And Pathology Private Limited. The most recent appointment on record is 01 Jun 2025 at Sahid Khudiram Bose Hospital.

The 2 current companies of Shitla Prasad Upadhyay that report revenue have a combined latest revenue of ₹14.99 Cr: Sahid Khudiram Bose Hospital ₹14.96 Cr (FY 2022); Cure And Care Polyclinic And Pathology Private Limited ₹2.9 Lakh (FY 2024).

The current boards of Shitla Prasad Upadhyay's companies include Ashis Kumar Saha (Sahid Khudiram Bose Hospital), Govinda Ganguly (Sahid Khudiram Bose Hospital), Hemanta Kumar Ray (Sahid Khudiram Bose Hospital), Subrata Dasgupta (Sahid Khudiram Bose Hospital), Suprieo Bhadra (Sahid Khudiram Bose Hospital), Rajnish Kumar Upadhyay (Cure And Care Polyclinic And Pathology Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available